Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Achilles Therapeutics Plc (NQ: ACHL ) 0.8589 +0.0010 (+0.12%) Streaming Delayed Price Updated: 3:31 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 11,111 Open 0.8298 Bid (Size) 0.8212 (11) Ask (Size) 0.8588 (20) Prev. Close 0.8579 Today's Range 0.8201 - 0.8713 52wk Range 0.7400 - 1.760 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines May 22, 2024 From Achilles Therapeutics PLC Via GlobeNewswire ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024 May 08, 2024 ACHL stock results show that Achilles Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Performance YTD -1.50% -1.50% 1 Month -4.78% -4.78% 3 Month +5.45% +5.45% 6 Month +0.90% +0.90% 1 Year -18.97% -18.97% More News Read More Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights May 08, 2024 From Achilles Therapeutics PLC Via GlobeNewswire Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results April 04, 2024 Via Benzinga Topics Stocks Exposures US Equities Achilles Therapeutics: Q1 Earnings Insights May 10, 2023 Via Benzinga Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session April 04, 2024 Via Benzinga Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings April 04, 2024 Via Benzinga Topics Stocks Exposures US Equities ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023 April 04, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session April 04, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 04, 2024 Via InvestorPlace Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights April 04, 2024 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning April 04, 2024 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference February 05, 2024 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction December 18, 2023 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights November 13, 2023 From Achilles Therapeutics PLC Via GlobeNewswire 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis October 23, 2023 Via ACCESSWIRE Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation September 20, 2023 Via Investor Brand Network Exposures Product Safety Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation September 20, 2023 Via FinancialNewsMedia Exposures Product Safety 12 Health Care Stocks Moving In Thursday's After-Market Session September 07, 2023 Via Benzinga Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights August 04, 2023 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics to Present at Upcoming Conferences June 12, 2023 From Achilles Therapeutics PLC Via GlobeNewswire 3 Stocks With 1,000% Upside Potential May 21, 2023 Via InvestorPlace Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights May 10, 2023 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens May 10, 2023 From Achilles Therapeutics PLC Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
